NO923929L - Vasoaktive cykliske polypeptider - Google Patents

Vasoaktive cykliske polypeptider

Info

Publication number
NO923929L
NO923929L NO92923929A NO923929A NO923929L NO 923929 L NO923929 L NO 923929L NO 92923929 A NO92923929 A NO 92923929A NO 923929 A NO923929 A NO 923929A NO 923929 L NO923929 L NO 923929L
Authority
NO
Norway
Prior art keywords
vasoactive
peptide
amino acid
chain
present
Prior art date
Application number
NO92923929A
Other languages
English (en)
Other versions
NO304523B1 (no
NO923929D0 (no
Inventor
David Robert Bolin
Margaret O'donnell
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO923929D0 publication Critical patent/NO923929D0/no
Publication of NO923929L publication Critical patent/NO923929L/no
Publication of NO304523B1 publication Critical patent/NO304523B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO923929A 1991-10-11 1992-10-09 Vasoaktive cykliske polypeptider NO304523B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77374791A 1991-10-11 1991-10-11

Publications (3)

Publication Number Publication Date
NO923929D0 NO923929D0 (no) 1992-10-09
NO923929L true NO923929L (no) 1993-04-13
NO304523B1 NO304523B1 (no) 1999-01-04

Family

ID=25099195

Family Applications (3)

Application Number Title Priority Date Filing Date
NO923929A NO304523B1 (no) 1991-10-11 1992-10-09 Vasoaktive cykliske polypeptider
NO975023A NO975023D0 (no) 1991-10-11 1997-10-31 Vasoaktive cykliske polypeptider
NO980377A NO980377D0 (no) 1991-10-11 1998-01-28 Vasoaktive cykliske peptider

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO975023A NO975023D0 (no) 1991-10-11 1997-10-31 Vasoaktive cykliske polypeptider
NO980377A NO980377D0 (no) 1991-10-11 1998-01-28 Vasoaktive cykliske peptider

Country Status (26)

Country Link
US (1) US5677419A (no)
EP (1) EP0536741B1 (no)
JP (1) JP2515473B2 (no)
KR (1) KR970001580B1 (no)
CN (3) CN1034943C (no)
AT (1) ATE132165T1 (no)
AU (1) AU656230B2 (no)
BG (1) BG61125B2 (no)
BR (1) BR9203959A (no)
CA (1) CA2080272C (no)
CZ (1) CZ281818B6 (no)
DE (1) DE69207138T2 (no)
DK (1) DK0536741T3 (no)
ES (1) ES2082317T3 (no)
FI (2) FI111646B (no)
GR (1) GR3019326T3 (no)
HU (2) HUT62606A (no)
IL (3) IL103396A (no)
MX (1) MX9205822A (no)
NO (3) NO304523B1 (no)
NZ (1) NZ244644A (no)
RU (1) RU2095368C1 (no)
SK (1) SK279399B6 (no)
TW (1) TW305846B (no)
UY (2) UY23488A1 (no)
ZA (1) ZA927724B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
AU722895B2 (en) * 1996-02-09 2000-08-10 F. Hoffmann-La Roche Ag Synthesis of VIP analog
DE69738353T2 (de) 1996-07-12 2009-09-24 Immunomedics, Inc. Radiometall-bindende peptide analoge
WO1998002453A2 (en) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
CA2379604A1 (en) * 1999-09-28 2001-04-05 Bayer Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
AU2000263935A1 (en) 2000-02-18 2001-08-27 Dabur Research Foundation Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
WO2001060862A1 (en) 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
US7507714B2 (en) * 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
WO2002043746A2 (en) 2000-11-28 2002-06-06 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
CN1313149C (zh) 2002-06-10 2007-05-02 蒙杜生物科技安斯塔特实验室 具有血管活性肠肽的生物学活性的化合物在治疗结节病中的用途
CA2554475A1 (en) * 2004-01-27 2005-08-11 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
WO2006023358A1 (en) * 2004-08-18 2006-03-02 Eli Lilly And Company Selective vpac2 receptor peptide agonists
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
WO2007101146A2 (en) * 2006-02-28 2007-09-07 Eli Lilly And Company Selective vpac2 receptor peptide agonists
CN101484468A (zh) * 2006-07-06 2009-07-15 霍夫曼-拉罗奇有限公司 新型血管活性肠肽类似物
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
SG10201407329RA (en) 2009-08-14 2015-01-29 Phasebio Pharmaceuticals Inc Modified vasoactive intestinal peptides
US9782454B2 (en) * 2010-04-22 2017-10-10 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9561262B2 (en) 2011-06-06 2017-02-07 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
CN114652817A (zh) 2015-02-09 2022-06-24 费斯生物制药公司 用于治疗肌肉疾病和病症的方法和组合物
KR102243870B1 (ko) 2016-09-30 2021-04-22 후지필름 가부시키가이샤 환상 펩타이드, 어피니티 크로마토그래피 담체, 표지화 항체, 항체 약물 복합체 및 의약 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
FI20002041A (fi) 2000-09-15
KR970001580B1 (ko) 1997-02-11
CZ281818B6 (cs) 1997-02-12
EP0536741A3 (no) 1994-04-06
CN1153785A (zh) 1997-07-09
JPH05213996A (ja) 1993-08-24
SK279399B6 (sk) 1998-11-04
ES2082317T3 (es) 1996-03-16
BG61125B2 (bg) 1996-11-29
HU211534A9 (en) 1995-12-28
CA2080272C (en) 2002-09-17
US5677419A (en) 1997-10-14
CN1152579A (zh) 1997-06-25
RU2095368C1 (ru) 1997-11-10
CN1225473C (zh) 2005-11-02
ATE132165T1 (de) 1996-01-15
UY23488A1 (es) 1993-04-20
UY25084A1 (es) 1998-12-21
SK308692A3 (en) 1995-03-08
NZ244644A (en) 1995-04-27
EP0536741A2 (en) 1993-04-14
NO304523B1 (no) 1999-01-04
CA2080272A1 (en) 1993-04-12
HUT62606A (en) 1993-05-28
TW305846B (no) 1997-05-21
IL103396A (en) 1997-11-20
DE69207138D1 (de) 1996-02-08
CN1198841C (zh) 2005-04-27
FI111646B (fi) 2003-08-29
NO975023D0 (no) 1997-10-31
GR3019326T3 (en) 1996-06-30
CN1034943C (zh) 1997-05-21
KR930007972A (ko) 1993-05-20
IL103396A0 (en) 1993-03-15
AU656230B2 (en) 1995-01-27
FI924580A0 (fi) 1992-10-09
HU9203194D0 (en) 1992-12-28
AU2622892A (en) 1993-04-22
CN1072415A (zh) 1993-05-26
CZ308692A3 (en) 1993-08-11
NO975023L (no) 1993-04-13
NO980377L (no) 1993-04-13
IL117252A0 (en) 1996-06-18
JP2515473B2 (ja) 1996-07-10
DK0536741T3 (da) 1996-04-22
FI924580A (fi) 1993-04-12
DE69207138T2 (de) 1996-06-13
MX9205822A (es) 1993-06-01
EP0536741B1 (en) 1995-12-27
ZA927724B (en) 1994-04-07
NO923929D0 (no) 1992-10-09
IL117252A (en) 1999-11-30
NO980377D0 (no) 1998-01-28
BR9203959A (pt) 1993-04-27

Similar Documents

Publication Publication Date Title
NO923929L (no) Vasoaktive cykliske polypeptider
IL142025A0 (en) Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds
DK601786A (da) Hidtil ukendte prokoagulationsproteiner
DK0673948T3 (da) Peptider, der stammer fra et retrovirus fra HIV-gruppen, og deres anvendelse
FR2744134B1 (fr) Proteines de reserve de plantes enrichies en acides amines, notamment alpha-zeine de mais enrichie en lysine plantes exprimant ces proteines
ATE201696T1 (de) Zyklische peptidanaloga von somatostatin
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
FI964363A (fi) Peptidejä
EP0333587A3 (en) Method for purifying and isolating carboxyl-terminal peptides
FI942392A (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
ATE46173T1 (de) Pharmakologisch aktive peptide.
AU2003260306A1 (en) Bicyclic oligopeptides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2002